J.B. Hunt sees lower volumes, weaker demand; stock drops 6%
By Claudia Assis
Cost increases also contributed to lower bottom line, trucking company
Shares of J.B. Hunt Transport Services Inc. fell 6% in the extended session Tuesday after the transportation company reported drops in its quarterly profit and revenue after weaker demand.
The declines were a "combination of lower volumes and yield pressure" in several of its businesses, plus cost increases related to equipment, insurance and claims, the company said.
J.B. Hunt (JBHT) earned $127.5 million, or $1.22 a share, in the first quarter, compared with $197.8 million, or $1.89 a share, in the year-ago quarter.
Revenue dropped 9% to $2.94 billion, from $3.23 billion a year ago.
Analysts polled by FactSet expected GAAP earnings of $1.53 a share on revenue of $3.11 billion.
Revenue from both J.B. Hunt's intermodal and truckload segments fell by 9%, and the company saw 22% fewer loads in its freight brokerage and logistics division.
Those declines were only partially offset by 2% growth in its last-mile business, thanks to new contracts, the company said.
Shares of J.B. Hunt are down 8% so far this year, contrasting with gains of about 6% for the S&P 500 index SPX in the same period.
-Claudia Assis
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
04-16-24 1652ET
Copyright (c) 2024 Dow Jones & Company, Inc.-
What’s Happening In the Markets This Week
-
How the Tokyo Stock Exchange Is Pushing for Better Shareholder Returns
-
Magnificent 7 Stocks Earnings Updates: AI Remains the Focus
-
Where We See Opportunities After an Ugly Month for Stocks
-
After Earnings, Is Alphabet Stock a Buy, a Sell, or Fairly Valued?
-
When Will the Fed Start Cutting Interest Rates?
-
What’s the Difference Between the CPI and PCE Indexes?
-
Powell Unfazed By Sticky Inflation, but Rate Cuts Are Far Off
-
3 Dividend Stocks for May 2024
-
Amgen Earnings: Obesity Drug Update Is Highly Encouraging
-
What’s Going on With Apple, Tesla, and Alphabet?
-
Apple Earnings: A Weak 2024, but Optimism for 2025
-
4 Utility Stocks to Play the AI Data Center Boom
-
Albemarle Earnings: We Expect Improved Results In the Rest of Year Following Cyclically Low Profits
-
Novo Nordisk Earnings: Raised Fair Value Estimate Still a Contrast to Market Overenthusiasm
-
After Earnings, Is Verizon Stock a Buy, a Sell, or Fairly Valued?